Stroke remains a leading cause of mortality and morbidity worldwide. Rapid identification and treatment are crucial for improving patient outcomes. This article aims to provide a concise guide for healthcare professionals on early stroke recognition and management.
Early stroke recognition is pivotal. The acronym FAST—Face drooping, Arm weakness, Speech difficulty, Time to call 911—provides a useful guide. However, additional symptoms such as sudden confusion, trouble seeing, difficulty walking, and severe headache without known cause should also alert clinicians to potential stroke.
Upon suspicion of stroke, immediate neuroimaging, preferably with a non-contrast CT scan, is essential to distinguish ischemic from hemorrhagic stroke. Other diagnostic tools include physical examination, blood tests, carotid ultrasound, cerebral angiogram, and echocardiography.
Once stroke is confirmed, time is of the essence. For ischemic stroke, intravenous thrombolysis with recombinant tissue plasminogen activator (rtPA) should be initiated within 4.5 hours of symptom onset. If contraindications to rtPA exist or if the patient presents beyond the therapeutic window, mechanical thrombectomy may be considered.
Hemorrhagic stroke management is different and mainly involves controlling bleeding, reducing pressure in the brain, and stabilizing vital signs. Surgery may be needed to repair blood vessel abnormalities.
After acute management, comprehensive rehabilitation is crucial to maximize patient recovery. This includes physical, occupational, and speech therapy, alongside secondary prevention measures to reduce stroke recurrence risk.
Early stroke recognition and prompt, appropriate management can significantly improve patient outcomes. Continued education and training in stroke recognition and treatment for healthcare professionals are vital for reducing stroke-related disability and death.
1.
Tumor characteristics found to differ for melanomas in children, teens and young adults
2.
Unexplained CAR-T Death; Americans Spurn Sunscreen; Improving Diversity in Trials
3.
"A lot" of aspirin reduces the risk of ovarian cancer, regardless of genetic factors, according to the JAMA study.
4.
Approval in Endometrial Cancer Expanded; Masks at Cancer Centers; NPR Reporter Dies
5.
Is Lenalidomide Resistance in Myeloma Reversible with JAK Inhibition?
1.
Modern Oncology Unveiled with Treatment Innovations and Personalized Cancer Care
2.
Screening for Early Therapy-Related Cancer Susceptibility
3.
Unlocking the Potential of Bicalutamide 50 mg: A Revolutionary New Treatment for Prostate Cancer
4.
Skin-Sparing Mastectomy: Balancing Cancer Control with Cosmetic Results
5.
Reducing Modifiable Childhood Cancer Exposure Risks
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
2.
Targeting Oncologic Drivers with Dacomitinib: Further Discussion on Lung Cancer Treatment
3.
Should We Use DARA Up Front As First-Line Therapy in MM?
4.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option- A New Perspective
5.
Importance of Cancer Screening and Early Detection
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation